Search

A recent study conducted at the University of Cagliari in Italy focused on pregnancy and childbirth in women with beta transfusion-dependent thalassemia (TDT). The research highlighted improvements in disease management and their impact on pregnancy outcomes. The study analyzed data from 341 pregnancies in 247 women with TDT, showing an increase in the age at first pregnancy over time and various methods of conception. The study also found that the rate of complications during pregnancy was not significantly higher compared to the non-thalassemic population, and neonatal characteristics have evolved over time alongside advancements in disease management. [Extracted from the article]

Keywords: Milan; Italy; Europe; Bioengineering; Biotechnology; Clinical Trials and Studies; Congenital Anemia; Drugs and Therapies; Gene Therapy; Genetics; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Hemic and Lymphatic Diseases and Conditions; Hemoglobinopathies; Hemolytic; Pediatrics; Pharmaceuticals; Post-Trial Research; Sickle Cell Anemia; Thalassemia; Therapy EN Milan Italy Europe Bioengineering Biotechnology Clinical Trials and Studies Congenital Anemia Drugs and Therapies Gene Therapy Genetics Health and Medicine Hematologic Diseases and Conditions Hematology Hemic and Lymphatic Diseases and Conditions Hemoglobinopathies Hemolytic Pediatrics Pharmaceuticals Post-Trial Research Sickle Cell Anemia Thalassemia Therapy 577 577 1 04/17/23 20230421 NES 230421 2023 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- New research on Biotechnology - Gene Therapy is the subject of a report. What is Known: • Red blood cell transfusions, iron chelation therapy and hematopoietic stem cell transplantation have been the mainstay of treatment of thalassemia patients for decades. [Extracted from the article]